Jian-Ting Zhang

8PUBLICATIONS
10CO-AUTHORS
Proteins and peptidesMolecular targetsReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 13, 2023
Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.

Qingbin Cui, Caoqinglong Huang, Jing-Yuan Liu

|Oct 18, 2022
Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid Synthase.

Jenny Beebe, Sophia Josephraj, Chao J Wang

|Mar 13, 2022
eIF3a regulation of mTOR signaling and translational control via HuR in cellular response to DNA damage.

Shijie Ma, Zizheng Dong, Yanfei Huang

|Aug 17, 2021
Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC.

Sagar D Sardesai, Alexandra Thomas, Christopher Gallagher

|May 19, 2020
Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation.

Robert Peery, Kwaku Kyei-Baffour, Zizheng Dong

|Nov 14, 2019
Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs.

Wenji Zhang, Yang Yang, Zizheng Dong

Pageof 2

Frequent Collaborators

2 joint publications

Qingbin Cui

1 joint publications

Zhi Shi

1 joint publications

Mingji Dai

1 joint publications

Sagar D Sardesai